16.06.2022 10:15:03
|
Hardman & Co Research: Q&A on Chesnara Plc (CSN): Good performance analysed
Hardman & Co Research
Analyst interview | Financials Q&A with Brian Moretta on Chesnara Plc (CSN) | Good performance analysed Chesnara plc (CSN) is the company of discussion when Dr Brian Moretta, Analyst at Hardman & Co joins DirectorsTalk Interviews. In this interview Brian explains how the company performed over the full year, discusses the operational challenges, updates us on the dividend, progress with its acquisition strategy and immediate prospects. Listen to the interview here
If you are interested in meeting the company, you can register your interest here
Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement. About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
1376711 16-Jun-2022
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Chesnara PLCmehr Nachrichten
11.10.24 |
Hardman & Co Q&A on Chesnara plc (CSN): 2024 interim results a steady performance (EQS Group) | |
01.10.24 |
Hardman Talks Video | Chesnara plc (CSN): Presentation and Q&A with Management (EQS Group) | |
26.09.24 |
Hardman & Co Research on Apax Global Alpha (APAX): 1H’24 deal activity coming back strongly (EQS Group) |